EI
RVMD icon

Ellevest Inc’s Revolution Medicines RVMD Stock Holding History

Ellevest Inc’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-18
Closed -$390 – 1366
2023
Q1 		$390 Buy
+18
New +$443 ﹤0.01% 1705
2021
Q3 		– Sell
-20
Closed -$1K – 1548
2021
Q2 		$1K Buy
+20
New +$698 ﹤0.01% 1194

Other funds holding RVMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ellevest Inc's RVMD Position: Q2 2023 in Review

Ellevest Inc sold out of Revolution Medicines (RVMD) in Q2 2023, closing a stake of 18 shares — an estimated $390 sold.

Ellevest Inc first reported a position in RVMD in Q2 2021 and held it in 2 quarters. The position peaked at $1K in Q2 2021. 139 funds tracked by Wall St. Rank hold RVMD as of Q2 2023.

  • Ellevest Inc reported no remaining Revolution Medicines position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 18 Revolution Medicines shares in Q2 2023, an estimated $390.
  • Ellevest Inc first reported a position in Revolution Medicines in Q2 2021 and held it in 2 quarters.
  • Ellevest Inc's Revolution Medicines position peaked at $1K in Q2 2021.
  • 139 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.